EUVIMEDEUVIMED entdecken
Crossref

Hydrogen Sulfide Treatment Enhanced Paclitaxel's Anticancer Effect on the ID8 Murine Epithelial Ovarian Cancer Cell Line

Gökçe Sevim Öztürk Fincan iD, Ayşe Kübra Kibar Güzin iD, Atiye Seda Yar Sağlam iD

Fundamental & Clinical Pharmacology · 2025

DOI: 10.1111/fcp.70029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2025. Verfasst von Gökçe Sevim Öztürk Fincan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Gazi University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Paclitaxel, Ovarian Neoplasms, Hydrogen Sulfide, Neoplasms, Glandular and Epithelial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Paclitaxel is a potent agent against ovarian cancer. Hydrogen sulfide (H 2 S) is of particular interest in cancer treatment research. It is known that H 2 S has apoptotic and antiproliferative effects.

Objectives

We aimed to examine the potential effects of H 2 S donor NaHS and paclitaxel, both individually and when co‐administered, on the ID8 murine epithelial ovarian cancer cell line.

Methods

We examined the effects of the co‐administration of paclitaxel and NaHS on cell viability, cytotoxicity, reactive oxygen species (ROS) levels, mitochondrial membrane potential (MMP), apoptosis, and proliferation in the ID8 ovarian cancer cell line. 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide and lactate dehydrogenase tests were performed to ascertain the effect of NaHS and paclitaxel on cell viability and cytotoxicity. Caspase 3/7 levels were quantified in order to detect whether apoptosis is caspase dependent. Quantitative real‐time polymerase chain reaction (qPCR) method was used to ascertain relative mRNA levels of Bcl‐2, Bcl‐xL, Bax, and Bak genes.

Results

The viability of ID‐8 cells showed a significant reduction following the co‐administration of paclitaxel and NaHS, compared to the paclitaxel administration only. The results of qPCR analysis demonstrated significant alterations in the Bcl‐2, Bcl‐xL, Bax, Bak, Casp3, Casp8, and Casp9 genes' mRNA levels following cotreatment. In contrast to paclitaxel alone, its co‐administration with NaHS resulted in increased apoptosis and decreased ROS levels. The presence of NaHS has been observed to enhance the apoptotic impact of paclitaxel by amplifying the decline in MMP.

Conclusion

These data indicate that co‐administration of H 2 S with paclitaxel could be useful as a potential agent in the treatment of ovarian cancer. We found that the presence of H 2 S enhanced the antitumor efficacy of paclitaxel.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelOvarian NeoplasmsHydrogen SulfideNeoplasms, Glandular and EpithelialAntineoplastic Agents, PhytogenicAnimalsFemaleMiceCell Line, TumorCarcinoma, Ovarian EpithelialApoptosisCell SurvivalReactive Oxygen SpeciesMembrane Potential, MitochondrialCell ProliferationDrug SynergismSulfides

Stichwörter der Autor:innen

ID8 cellsapoptosishydrogen sulfideovarian cancerpaclitaxel

Substanzen

PaclitaxelReactive Oxygen SpeciesHydrogen SulfideSulfidesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Medical Pharmacology, Faculty of Medicine, Gazi University, Ankara, Türkiye.
  • Turkish Medicines and Medical Devices Agency, Republic of Türkiye Ministry of Health, Ankara, Türkiye.
  • Department of Medical Biology, Faculty of Medicine, Gazi University, Ankara, Türkiye.

ORCID-Profile: Gökçe Sevim Öztürk Fincan, Ayşe Kübra Kibar Güzin, Atiye Seda Yar Sağlam

Zitieren

APA

Öztürk Fincan, G. S., Kibar Güzin, A. K., & Yar Sağlam, A. S. (2025). Hydrogen Sulfide Treatment Enhanced Paclitaxel's Anticancer Effect on the ID8 Murine Epithelial Ovarian Cancer Cell Line. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.70029

Vancouver

Öztürk Fincan GS, Kibar Güzin AK, Yar Sağlam AS. Hydrogen Sulfide Treatment Enhanced Paclitaxel's Anticancer Effect on the ID8 Murine Epithelial Ovarian Cancer Cell Line. Fundamental & Clinical Pharmacology. 2025. doi:10.1111/fcp.70029

BibTeX
@article{ztrkFincan2025,
  author = {Öztürk Fincan, Gökçe Sevim and Kibar Güzin, Ayşe Kübra and Yar Sağlam, Atiye Seda},
  title = {Hydrogen Sulfide Treatment Enhanced Paclitaxel's Anticancer Effect on the ID8 Murine Epithelial Ovarian Cancer Cell Line},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2025},
  doi = {10.1111/fcp.70029}
}
Kostenlos starten →